IFNA1 and cryohydrocytosis: Also, IFN-α therapy alone, for Chronic Hepatitis C (CHC) is not satisfactory, because more than two third of treated patients will not have a sustained response; thus, it would be desirable to add some new effective drugs for use in combination therapy to improve the response rate.[11].